Financial Performance & Outlook - ONE Gas expects net income for 2026 to be in the range of $294 million to $302 million[12] - The company anticipates an EPS range of $4.65 to $4.77 per diluted share, assuming approximately 63.4 million diluted shares outstanding[12] - Long-term net income growth is projected at 7-9% for the 2025-2030 period[21] - Long-term EPS growth is expected to be 5-7%, raised from a previous estimate of 4-6%[21] Capital Investments & Rate Base - 2026 capital investments are estimated at approximately $800 million, with around $230 million allocated to customer growth[12] - The average rate base for 2026 is projected to be approximately $6.3 billion[12] - Capital investments from 2022 to 2026G are: System Integrity ~$2.5 billion, Customer Growth ~$1.2 billion[21] - Average annual rate base growth is expected to be 7-9%[21] Financing Activities - ONE Gas completed a $250 million term loan in August 2025, maturing in September 2026[12] - The company has forward sale agreements covering approximately 2.9 million shares at an average price of ~$78/share, totaling ~$226 million[12, 16] - Net long-term financing needs through 2030 are estimated at ~$1.3 billion, with approximately 30% expected to be equity issuances[14] Market Position - ONE Gas has a 71% market share in Kansas, 89% in Oklahoma, and 13% in Texas[8]

BEACON Trial Investigation Results - Internal investigation indicates anomalous efficacy results in the BEACON trial are likely due to patient-specific factors rather than issues with the drug product or study conduct[23] - A KOL panel review suggested that 9 out of 10 patients who did not respond in the US may not have had CSU, highlighting potential misdiagnosis issues common in CSU studies where 25%-30% of patients are incorrectly diagnosed[40] - Redosing Cohort 8 & 9 patients with a different drug product lot did not significantly change efficacy outcomes, with no incremental efficacy observed in 8 of 9 patients redosed[27, 31] - In the BEACON trial, 7 of 10 US patients in Cohorts 8 & 9 were switched to a different drug product lot by week 16[27, 31] ETESIAN Trial Interim Results - A single 180mg dose of Briquilimab in the ETESIAN study demonstrated a reduction in serum tryptase levels at 6 weeks, consistent with previous observations[45] - Briquilimab mitigated the effects of allergen challenge on FEV1 response, showing a sustained impact on asthmatic response at 6 and 12 weeks[47] - Briquilimab dramatically reduced airway hyper-responsiveness, increasing the concentration of methacholine needed to drive a 20% drop in FEV1 (PD20)[51] - Sputum eosinophil response was suppressed by Briquilimab at both 6-week and 12-week allergen challenge timepoints[53] Program Status and Next Steps - In CSU, single doses of 240mg and 360mg of Briquilimab led to more than a 24-point drop in UAS7, with 82% CR and 91% WC disease by week 4 (n=11)[60] - In an OLE study for CSU, 180mg Q8W of Briquilimab resulted in 73% CR and 82% WC disease at 12 weeks (n=11)[60]

This presentation may include statements expressing Vale's expectations regarding future events or results, including, without limitation : (i) on slide 5 , iron ore, copper, and nickel production guidance in 2025 ; (ii) on slide 6 , completion of dam decharacterization projects and emergency level reductions ; (iii) on slides 11 and 19 , leading positions in value creation in the mining industry and iron ore production, in addition to accelerating growth to double copper production capacity, (iv) on slide ...

Forward-Looking Statements - Certain statements constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 [3] - These statements are based on expectations and assumptions that may not be accurate [3] - Actual results could differ materially due to various risks, uncertainties, and circumstances [3] - The company assumes no obligation to update or revise any forward-looking statement [4] Risk Factors - General economic and industry conditions, including regulatory changes, pose risks [3] - Reliance on commercial airline customers is a significant factor [3] - The health of the aircraft production system and production quality issues are critical [3] - Dependence on subcontractors and suppliers, as well as labor and raw material availability, are important [3] - The pending acquisition of Spirit AeroSystems Holdings, Inc presents both opportunities and risks [3] - Potential business disruptions, including IT system threats and extreme weather, could have adverse effects [3]

Energy Storage Systems for Data Centers - The global server market is experiencing a compound annual growth rate (CAGR) of 34% from 2023 to 2028, driven by AI server adoption[15] - Panasonic Energy aims to achieve sales of 800 billion yen by FY2029 through increased demand for existing and next-generation products[28] - Panasonic Energy targets a Return on Invested Capital (ROIC) greater than 20% for its Energy Solutions Business Division by FY2029[46] - Panasonic Energy plans to increase cell production capacity by approximately 3 times by FY2029 compared to FY2026 levels[35] Electrical Construction Materials Business - Panasonic Electric Works aims to increase overseas sales to account for 35% of total sales by FY3/31, including 200 billion yen in India[62] - The Japanese market for electrical equipment is expected to grow at a CAGR of 0.7% from FY3/23 to FY3/31, reaching 2 trillion yen[59] - The Indian market for electrical equipment is projected to grow at a CAGR of 9.1% from FY3/23 to FY3/31, reaching 3.6 trillion yen[59] - Panasonic Electric Works targets a solutions sales ratio of 50% in Japan by FY3/31, up from 36% in FY3/25[88] SCM Software - The SCM software market is projected to reach 66553 million USD by 2029[99] - Blue Yonder's revenue for FYDec'24 was 1360 million USD[102] - Blue Yonder has achieved 150 million USD in cumulative cost savings as of 2025[114]

CANGO 03-2025 Earnings Presentation December 2025 CANG LISTED ENYSE 1 2 Mined a total of 1,930.8 BTC during the quarter, bringing the Company's BTC treasury to 5,810.1 BTC by quarter end. 5,810.1 BTC HODL as of September 30, 2025 $662.3 M Value of BTC HODL 2 as of September 30, 2025 Q3 Operational Highlights Cango operates 50 EH/s of deployed hashrate globally and maintains an average operating efficiency above 90% since November 2024 till September 2025. 50 EH/s Deploved Hashrate as of September 30 , 2025 ...

Portfolio Repositioning and Performance - Broadstone Net Lease (BNL) reduced clinical healthcare exposure to 2.4% of the portfolio ABR since the beginning of 2024[25] - BNL successfully sold 57 clinical healthcare assets for $352 million in 2024[25] - BNL grew AFFO per share by 1.4% in 2024 despite portfolio repositioning[25] - BNL's industrial exposure increased from 51.8% to 61.2% between March 31, 2023, and September 30, 2025[89] Growth Strategy and Build-to-Suit Developments - BNL has committed or completed $898 million in build-to-suit developments since 2023[25,59] - This includes $583 million of new build-to-suit commitments in 2025, expected to result in $29.1 million of incremental ABR through 1Q27[25,52] - BNL's build-to-suit strategy creates stabilized values approximately 75-100 bps tighter than initial cash yields[25] Financial Guidance and Shareholder Value - BNL's 2026 AFFO per share guidance is $1.53 - $1.57[329] - BNL's total shareholder return since the beginning of 2023 is 32.8%[25] - BNL's 2025 investment guidance is $650 - $750 million, and dispositions are $75 - $100 million[329]

Green Bay Project Resource Update - The Green Bay Project has an upgraded resource of 50.4 million tonnes @ 2.0% CuEq for 863kt Cu and 546koz Au in M&I[3] - The Green Bay Project has 29.3 million tonnes @ 2.5% CuEq for 566kt Cu and 563koz Au in Inferred[3] - The Green Bay Project has an exceptional high-grade core zone of 8.8 million tonnes @ 3.9% CuEq (346kt CuEq) in M&I and 10.9 million tonnes @ 3.8% CuEq (414kt CuEq) Inferred[3] - Since acquisition (2 years) the M&I category at Ming has grown 121% (from 21.5Mt to 47.5Mt) now making up 67% of the Ming MRE[43] - The Ming Mine has M&I Resource of 48Mt @ 2.0% CuEq and Inf Resource of 23Mt @ 2.6% CuEq[48] Financing and Development - A$139.5 million Equity Raise To Drive Growth and Development[33] - The company has A$244.5 million Pro-Forma Cash Balance[32] - The company is planning upscaled mine production & engineering studies well underway, scheduled for 1st half CY2026[80] - The company received environmental approval for start-up operation[80] Exploration and Regional Potential - The company has 3 x surface drill rigs targeting regional discovery; extensive geophysical surveys to continue[80] - The company identified 325x Geophysical targets for testing[65] - Initial Regional Drilling Intercepts High Grade at Rambler Main with 10.0m @ 6.4% CuEq and 12.9m @ 4.3% CuEq[68]

Transaction Overview - USA Compression Partners LP (USAC) 将以 8.6 亿美元收购 J-W Power Company (J-W)[2] - 交易对 J-W 的估值约为调整后 EBITDA 的 5.8 倍[3, 5] - USAC 将支付 4.3 亿美元现金，并通过发行约 1830 万股 USAC 普通股支付剩余部分[3] - J-W 拥有并运营超过 80 万马力 (HP) 的压缩设备[3] Strategic Rationale - 收购后，USAC 的有效马力将增加到约 440 万[5] - J-W 约 90% 的 2026 年预计调整后 EBITDA 与合同压缩业务相关[8] - J-W 的客户群非常多元化，与客户建立了超过 25 年的长期合作关系[3] - J-W 的前十大客户贡献了约 40% 的有效马力和收入[8] Geographic Footprint - J-W 的业务遍及美国主要盆地，其中 USGC/Mid-Con 占 34%，Permian 占 28%，Northeast 占 21%，Rockies 占 17%[7] - 收购后，USAC 在 USGC/Mid-Con 的业务占比为 74%，Permian 为 13%，Rockies 为 7%，Northeast 为 6%[11]

Financial Performance - Q3 2025 TCE income was USD 247 million, with a year-to-date (YTD) 9M 2025 figure of USD 6969 million[15] - Adjusted EBITDA for Q3 2025 reached USD 1505 million, and YTD 9M 2025 stood at USD 4097 million[15] - Net profit for Q3 2025 was USD 915 million (USD 018 per share), while YTD 9M 2025 amounted to USD 230 million (USD 046 per share)[15] - Dividends declared for Q3 2025 totaled USD 732 million (USD 01470 per share), representing 80% of the net profit[15] - Net LTV at the end of Q3 2025 improved to 205%[28] Fleet and Market Dynamics - As of November 14, 2025, 71% of the fleet's total earning days were covered for Q4 2025 at USD 25610 per day[16] - Approximately 88% of coated LR2 newbuilds have migrated into the Aframax dirty trading segment YTD 2025[43] - The effective increase in clean trading supply is only around 11 million DWT, equivalent to 05% clean trading supply growth after factoring in LR2 migration and sanctioned vessels[50] - Clean tonnage growth from 2025-2028 is projected to be around 11%, with nearly half of this increase expected in 2026[54] Strategic Initiatives - Hafnia entered into a joint venture with Cargill to create Seascale Energy, a stronger bunker procurement entity[21, 113] - The company has invested in several dual-fuel newbuilds, including LR2 LNG dual-fueled vessels and Chemical IMO-II MR Methanol dual-fueled vessels[114]